Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 77

1.

Prevalence of attention-deficit hyperactivity disorder in substance use disorder patients: a meta-analysis and meta-regression analysis.

van Emmerik-van Oortmerssen K, van de Glind G, van den Brink W, Smit F, Crunelle CL, Swets M, Schoevers RA.

Drug Alcohol Depend. 2012 Apr 1;122(1-2):11-9. doi: 10.1016/j.drugalcdep.2011.12.007. Epub 2011 Dec 30.

PMID:
22209385
2.

A qualitative review of issues arising in the use of psycho-stimulant medications in patients with ADHD and co-morbid substance use disorders.

Kollins SH.

Curr Med Res Opin. 2008 May;24(5):1345-57. doi: 10.1185/030079908X280707 . Epub 2008 Apr 1. Review.

PMID:
18384709
3.
4.

The diagnostic accuracy of attention-deficit/hyperactivity disorder in adults with substance use disorders.

Fatseas M, Debrabant R, Auriacombe M.

Curr Opin Psychiatry. 2012 May;25(3):219-25. doi: 10.1097/YCO.0b013e3283523d7c. Review.

PMID:
22449768
5.

The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.

Schubiner H, Tzelepis A, Isaacson JH, Warbasse LH 3rd, Zacharek M, Musial J.

J Clin Psychiatry. 1995 Apr;56(4):146-50. Review.

PMID:
7713853
6.

[Attention-deficit/hyperactivity disorder and substance abuse].

Davids E, Gastpar M.

Psychiatr Prax. 2003 May;30(4):182-6. Review. German.

PMID:
12768521
7.
8.

Impact of substance use disorder on ADHD and its treatment.

Wilens TE, Upadhyaya HP.

J Clin Psychiatry. 2007 Aug;68(8):e20. Review.

9.

Diagnosing ADHD in adults with substance use disorder: DSM-IV criteria and differential diagnosis.

Levin FR, Upadhyaya HP.

J Clin Psychiatry. 2007 Jul;68(7):e18. Review.

10.

Comorbid substance use disorders among youth with bipolar disorder: opportunities for early identification and prevention.

Goldstein BI, Bukstein OG.

J Clin Psychiatry. 2010 Mar;71(3):348-58. doi: 10.4088/JCP.09r05222gry. Epub 2009 Dec 1. Review.

PMID:
19961811
11.

[Substance use disorders and ADHD: an overview of recent Dutch research].

van Emmerik-van Oortmerssen K, Crunelle CL, Carpentier PJ.

Tijdschr Psychiatr. 2013;55(11):861-6. Review. Dutch.

12.

Attention deficit hyperactivity disorder and dual disorders. Educational needs for an underdiagnosed condition.

Martinez-Raga J, Szerman N, Knecht C, de Alvaro R.

Int J Adolesc Med Health. 2013;25(3):231-43. doi: 10.1515/ijamh-2013-0057. Review.

PMID:
23846135
13.

Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations.

Sullivan MA, Rudnik-Levin F.

Ann N Y Acad Sci. 2001 Jun;931:251-70. Review.

PMID:
11462745
15.

Comorbid attention deficit/hyperactivity disorder and substance use disorder: treatment considerations.

Klassen LJ, Bilkey TS, Katzman MA, Chokka P.

Curr Drug Abuse Rev. 2012 Sep;5(3):190-8. Review.

PMID:
22571450
16.
17.
18.

Substance abuse in patients with attention-deficit/hyperactivity disorder.

Bukstein O.

Medscape J Med. 2008 Jan 31;10(1):24. Review.

19.

[Summary of the practice guideline for the diagnosis and treatment of ADHD in adolescents and adults with addictions].

Matthys F, Joostens P, van den Brink W, Sabbe B.

Ned Tijdschr Geneeskd. 2013;157(24):A6025. Review. Dutch.

PMID:
23759179
20.

Alcohol, drugs, and attention-deficit/ hyperactivity disorder: a model for the study of addictions in youth.

Wilens TE, Biederman J.

J Psychopharmacol. 2006 Jul;20(4):580-8. Epub 2005 Sep 20. Review.

PMID:
16174669

Supplemental Content

Support Center